Table 1

Candida albicans strains used in this study

StrainParent strainGenotypeReference
SC5314ERG3/ERG313
CAF2-1SC5314ERG3/ERG312
DSY294Clinical isolateERG3/ERG3 (azole-susceptible clinical isolate)9
DSY296DSY294ERG3/ERG3 (azole-resistant clinical isolate)9
CAF4-2CAF2-1ura3Δ::imm434/ura3Δ::imm43412
DSY1216CAF4-2erg11Δ::hisG-URA3-hisG/ERG1138
DSY1217DSY1216erg11Δ::hisG/ERG1138
DSY1336DSY1217erg3AΔ::hisG-URA3-hisG/ERG3; erg11Δ::hisG/ERG1138
DSY1338CAF4-2erg3AΔ::hisG/ERG3; erg11Δ::hisG/ERG1138
DSY1751DSY1338erg3AΔ::hisG/erg3BΔ::hisG-URA3-hisG; erg11Δ::hisG/ERG1138
VSY2Clinical isolateerg3-1/erg3-1 (azole-resistant clinical isolate)This study
VSY9SC5314erg3-1::SAT1/ERG3This study
VSY10VSY9erg3-1::FRT/ERG3This study
VSY11VSY10erg3-1::FRT/erg3-1::SAT1This study
VSY12SC5314ERG3-2::SAT1/ERG3This study
VSY13VSY12ERG3-2::FRT/ERG3This study
VSY14VSY13ERG3-2::FRT/ERG3-2::SAT1This study
VSY15VSY2ERG3-2::SAT1/erg3-1This study
VSY16VSY15ERG3-2::FRT/erg3-1This study
VSY17VSY16ERG3-2::FRT/ERG3-2::SAT1This study
VSY18VSY11erg3-1::FRT/erg3-1::FRTThis study
VSY19VSY14ERG3-2::FRT/ERG3-2::FRTThis study
VSY20VSY17ERG3-2::FRT/ERG3-2::FRTThis study